Tech Company Financing Transactions
NOTA Laboratories Funding Round
NOTA Laboratories, operating out of Ann Arbor, raised investment from Pegasus Tech Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/15/2022
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Pegasus Tech Ventures (Lead Investor) (Bill Reichert)
Proceeds Purpose
Capital enables University of Michigan spinout to develop life-saving nitric oxide therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
600 South Wagner Rd. 6
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
NOTA Laboratories is focused on developing NO delivery platform technologies that have broad applicability in advancing the treatment for many debilitating and potentially life-threatening conditions and diseases, including Sars CoV-2 (COVID-19), the seasonal flu, the common cold, systemic inflammatory response syndrome (SIRS), chronic rhinosinusitis (CRS), COPD, and catheter related bloodstream infection (CRBSI).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Malcolm Kahn
Chief Financial Officer
Paul Rabinovich
Chief Medical Officer
Danial Drake
Chief Technical Officer
Mark Meyerhoff
VP - R & D
Glenn Martin
Browse more venture capital transactions:
Prev: 9/15/2022: Arpeggi Labs venture capital transaction
Next: 9/15/2022: Leanspace venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs